400
Participants
Start Date
September 18, 2020
Primary Completion Date
April 30, 2027
Study Completion Date
December 30, 2027
RECRUITING
University of Texas Southwestern, Dallas
RECRUITING
Cedars-Sinai Medical Center, Los Angeles
RECRUITING
UCLA, Los Angeles
RECRUITING
UCSF, San Francisco
RECRUITING
Kyoto University, Kyoto
Collaborators (1)
National Cancer Institute (NCI)
NIH
Nonagen Bioscience Corporation
INDUSTRY
University of California, San Francisco
OTHER
Kyoto University
OTHER
University of California, Los Angeles
OTHER
Cedars-Sinai Medical Center
OTHER